DK46687A - N6-substituerede adenosiner, fremgangsmaade til deres fremstilling og farmaceutisk komposition indeholdende forbindelserne - Google Patents

N6-substituerede adenosiner, fremgangsmaade til deres fremstilling og farmaceutisk komposition indeholdende forbindelserne

Info

Publication number
DK46687A
DK46687A DK046687A DK46687A DK46687A DK 46687 A DK46687 A DK 46687A DK 046687 A DK046687 A DK 046687A DK 46687 A DK46687 A DK 46687A DK 46687 A DK46687 A DK 46687A
Authority
DK
Denmark
Prior art keywords
procedures
compounds
preparation
pharmaceutical composition
composition containing
Prior art date
Application number
DK046687A
Other languages
English (en)
Other versions
DK46687D0 (da
Inventor
Alexander James Bridges
Harriet Wall Hamilton
Walter Hamilton Moos
Deedee Lynne Szotek
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK46687D0 publication Critical patent/DK46687D0/da
Publication of DK46687A publication Critical patent/DK46687A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/167Purine radicals with ribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK046687A 1986-01-31 1987-01-29 N6-substituerede adenosiner, fremgangsmaade til deres fremstilling og farmaceutisk komposition indeholdende forbindelserne DK46687A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82551386A 1986-01-31 1986-01-31
US06/936,766 US4755594A (en) 1986-01-31 1986-12-09 N6 -substituted adenosines

Publications (2)

Publication Number Publication Date
DK46687D0 DK46687D0 (da) 1987-01-29
DK46687A true DK46687A (da) 1987-08-01

Family

ID=27124913

Family Applications (1)

Application Number Title Priority Date Filing Date
DK046687A DK46687A (da) 1986-01-31 1987-01-29 N6-substituerede adenosiner, fremgangsmaade til deres fremstilling og farmaceutisk komposition indeholdende forbindelserne

Country Status (11)

Country Link
US (1) US4755594A (da)
EP (1) EP0232813A3 (da)
KR (1) KR910000602B1 (da)
AU (1) AU592728B2 (da)
CA (1) CA1270821A (da)
DK (1) DK46687A (da)
FI (1) FI870371A (da)
NO (1) NO165843C (da)
NZ (1) NZ219128A (da)
PH (1) PH23342A (da)
PT (1) PT84226B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5063233A (en) * 1986-11-14 1991-11-05 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
US4954504A (en) * 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
US4968697A (en) * 1987-02-04 1990-11-06 Ciba-Geigy Corporation 2-substituted adenosine 5'-carboxamides as antihypertensive agents
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
US5055569A (en) * 1989-10-19 1991-10-08 G. D. Searle & Co. N-(6)-substituted adenosine compounds
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US6004945A (en) 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US6180616B1 (en) 1990-05-10 2001-01-30 Atsuo F. Fukunaga Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
EP0550631B1 (en) * 1990-09-25 1997-01-02 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2687678B1 (fr) * 1992-01-31 1995-03-31 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
ES2227896T3 (es) * 1997-12-16 2005-04-01 Warner-Lambert Company Llc Derivados de 1-aminometil-cicloalcanos sustituidos en 1 (=analogos de gabapentina), su preparacion y su uso en el tratamiento de trastornos neurologicos.
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
HUP0103025A3 (en) 1998-06-23 2002-04-29 Glaxo Group Ltd A2a agonist 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives, medicaments containing the same, process for producing them and the useful intermediates
US6294522B1 (en) * 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
MY125533A (en) * 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
EP1375508A1 (en) * 2002-06-27 2004-01-02 Aventis Pharma Deutschland GmbH N6-substituted adenosine analogues and their use as pharmaceutical agents
US7265111B2 (en) * 2002-06-27 2007-09-04 Sanofi-Aventis Deutschland Gmbh Adenosine analogues and their use as pharmaceutical agents
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
CN101857622B (zh) * 2009-04-07 2014-12-03 中国医学科学院药物研究所 一种腺苷衍生物及其制备方法和应用
JP7136786B2 (ja) * 2017-01-27 2022-09-13 アカデミア シニカ 痛みの予防および治療に使用するための鎮痛効果を有する化合物
KR102308854B1 (ko) * 2021-02-26 2021-10-05 퓨쳐메디신 주식회사 카보사이클릭 뉴클레오사이드 유도체를 포함하는 코로나바이러스감염증-19 예방 및 치료용 약학적 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE329623B (da) * 1967-06-08 1970-10-19 C F Boehringer Soehne Gmbh
CH564032A5 (da) * 1971-07-06 1975-07-15 Boehringer Mannheim Gmbh
DE2406587A1 (de) * 1974-02-12 1975-08-21 Klinge Co Chem Pharm Fab Hypolipaemisch wirksame adenosinderivate
DE3019322A1 (de) * 1980-05-21 1981-12-03 Merck Patent Gmbh, 6100 Darmstadt Psychopharmakon sowie verwendung von adenosinderivaten
CA1239397A (en) * 1983-08-01 1988-07-19 James A. Bristol N.sup.6-substituted adenosines
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
US4657897A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
US4657898A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines and method of use
US4616003A (en) * 1984-10-26 1986-10-07 Warner-Lambert Company N6 -dihydroxypropyladenosines
CA1254888A (en) * 1984-10-26 1989-05-30 Bharat Trivedi N.sup.6-bicycloadenosines
US4593019A (en) * 1984-10-26 1986-06-03 Warner-Lambert Company N6 -tricyclic adenosines
US4614732A (en) * 1984-10-26 1986-09-30 Warner-Lambert Company N6 -acenaphthyl adenosines and analogs thereof
WO1988003147A1 (en) * 1986-10-31 1988-05-05 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
LU87181A1 (fr) * 1987-04-06 1988-11-17 Sandoz Sa Nouveaux derives de l'acide furannuronique,leur preparation et leur utilisation comme medicaments

Also Published As

Publication number Publication date
NO165843C (no) 1991-04-17
KR870007177A (ko) 1987-08-17
EP0232813A3 (en) 1989-03-22
US4755594A (en) 1988-07-05
NZ219128A (en) 1990-01-29
NO870390D0 (no) 1987-01-30
AU6797287A (en) 1987-08-06
FI870371A0 (fi) 1987-01-28
PT84226B (pt) 1989-05-31
DK46687D0 (da) 1987-01-29
NO165843B (no) 1991-01-07
EP0232813A2 (en) 1987-08-19
KR910000602B1 (ko) 1991-01-28
NO870390L (no) 1987-08-03
PT84226A (en) 1987-02-01
FI870371A (fi) 1987-08-01
CA1270821A (en) 1990-06-26
PH23342A (en) 1989-07-14
AU592728B2 (en) 1990-01-18

Similar Documents

Publication Publication Date Title
DK46687D0 (da) N6-substituerede adenosiner, fremgangsmaade til deres fremstilling og farmaceutisk komposition indeholdende forbindelserne
DK573384A (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
DK488885D0 (da) 9-amino-1,2,3,4-tetrahydroacridin-1-ol og beslaegtede forbindelser, enfremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
DK362787D0 (da) Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
IL88765A (en) N-hydroxycycloalkyl or n-hydroxycycloalkenyl- substituted adenosine derivatives, methods for their preparation and pharmaceutical compositions, including antilipolytic compositions, containing the same
DK590185D0 (da) Imidazoderivater, deres fremstilling og laegemiddel indeholdende saadanne forbindelser
DK371584D0 (da) N6-substituerede adenosiner, fremgangsmaade til deres fremstilling sam deres anvendelse
DK250387D0 (da) Di- og tetrahydroisoquinolin-derivater, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK408186D0 (da) Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne
DK592685A (da) Imidazoderivater, deres fremstilling og laegemiddel indeholdende saadanne forbindelser
DK435588A (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
DK133587A (da) 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne
DK457787D0 (da) Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
FI874414A (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
DK586188A (da) Kondenserede diazepinoner, fremgangsmaade til deres fremstilling og laegemidler med indhold af saadanne forbindelser
DK488585A (da) N6- substituerede adenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser
DE3781483D1 (de) Pharmazeutische zusammensetzung zum schutz von gehirnzellen.
DK617684A (da) 1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser
DK133387A (da) 5-fluoruracilderivater og fremgangsmaade til deres fremstilling
DK512185D0 (da) 3,4-diazolderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
DK163985A (da) Antivirale purinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK339285A (da) Pyridinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK127086A (da) Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
DK164317C (da) Quinoxalin-2,3-dion-forbindelser, fremgangsmaade til deres fremstilling og farmaceutiske praeparater hvori forbindelserne indgaar
DK354688D0 (da) Benzooe5,6aacycloheptapyridiner, kompositioner og fremgangsmaader til deres anvendelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment